Back to MORGAN STANLEY MORGAN STANLEY

KNSAKNSA
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in KINIKSA PHARMACEUTICALS INTL

MORGAN STANLEY holds 1M shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $64.7M as of 2026-Q2. The position was increased (+1.3% shares). KNSA represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$64.7M

Current Shares

1M

Total Value Change

+$27.6M

Total Shares Change

-974,343

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+1.3%
$64.7M0.0%$63.95
30
2026-Q1
Decreased
997,786
-26.6%
$48M0.0%$45.37
0
2025-Q4
Decreased
1.4M
-0.2%
$56.1M0.0%$40.99
0
2025-Q3
Increased
1.4M
+27.8%
$52.9M0.0%$38.77
37
2025-Q2
Decreased
1.1M
-0.9%
$29.5M0.0%$28.04
0
2025-Q1
Decreased
1.1M
-27.6%
$23.9M0.0%$23.09
0
2024-Q4
Increased
1.5M
+45.1%
$29.4M0.0%$19.60
39
2024-Q3
Decreased
1M
-48.4%
$25.6M0.0%$25.00
0
2024-Q2
New
2M
-
$37.1M0.0%$18.67
40

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used